ScottAArmstrongMD

Associate Professor of Pediatrics, Dana-Farber Cancer Institute

Dr. Armstrong is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 1996 - 1998
University of Texas Southwestern Medical SchoolClass of 1996

PubMed

104 citations
Exploiting the Epigenome to Control Cancer-Promoting Gene-Expression Programs
Gerard L. Brien, Daria G. Valerio, Scott A. Armstrong
Cancer Cell. 2016-04-11
3527 citations
The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease
Justin Lamb, Emily D. Crawford, David Peck, Joshua W. Modell, Irene C. Blat
Science. 2006-09-29
277 citations
Acute Myelogenous Leukemia-Induced Sympathetic Neuropathy Promotes Malignancy in an Altered Hematopoietic Stem Cell Niche
Maher Hanoun, Dachuan Zhang, Toshihide Mizoguchi, Sandra Pinho, Halley Pierce
Cell Stem Cell. 2014-09-04

Journal Articles

Article HOXA9 Reprograms the Enhancer Landscape to Promote Leukemogenesis
Ross L Levine, Jay L Hess, Sheng Cai, Scott A Armstrong, ScienceDirect

Abstracts/Posters

Rationale for Targeting BCL6 in MLL-Rearranged B-ALL
Scott A. Armstrong, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Leukemia Cell of Origin Influences p53 Activity and Therapeutic Sensitivity Via an Evi1-Dependent Mechanism
Scott A. Armstrong, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
A Phase Ib/II Study of the Histone Methyltransferase Inhibitor Pinometostat in Combination with Azacitidine in Patients with 11q23-Rearranged Acute Myeloid Leukemia
Scott A. Armstrong, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Tudor Domain-Focused CRISPR Dropout Screen Identifies SGF29 As a Novel Essential Gene in MLL-Rearranged Leukemias
Scott A. Armstrong, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Join now to see all

Lectures

Biochemical and Genetic Insights Into MLL/11q23 Translocation Leukemia
60th American Society of Hematology Annual Meeting - 12/2/2018
High-Density CRISPR Scan Identifies Functional Regions of DOT1L That Mediate Therapeutic Response in MLL-r Leukemia
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Dana-Farber/Boston Children's Ranked Among the Best Pediatric Cancer Programs in the Nation for 18th Year in a RowOctober 8th, 2024
Experimental Pill Sends a Third of Leukemia Patients into Complete Remission in an Early TrialMarch 24th, 2023
Experimental Pill Sends a THIRD of Patients with Leukemia into Complete Remission in Early TrialMarch 24th, 2023
Join now to see all

Molecular Pathogenesis Of MLL-AF4 LeukemiasNational Cancer Institute2010–2012
MLL Fusion Genes In Myeloid And Lymphoid LeukemiasNational Cancer Institute2008–2012
Comprehensive Phenotypic Comparison Of Normal And Cancer Stem CellsNational Cancer Institute2009–2010
The Core Apoptotic Pathway Controlling Glucocorticoid-Induced Apoptosis In AllNational Cancer Institute2006–2010
MLL Gene Regulation In Hematopoiesis And LeukemiaNational Cancer Institute2005–2006
MLL Gene Regulation In Hematopoiesis And LeukemiaNational Cancer Institute2001–2004